Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (841-850 of 850) with videos related to

Pageof 85
Sort By:
You have reached the last page of results.This site can display upto 850 results.
European Urology Oncology|June 28, 2021
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal TherapyCarlo A Bravi, Matteo Droghetti, Nicola Fossati, et al.
Prostate Cancer and Prostatic Diseases|November 4, 2025
High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancerNeele Heckmann, Henning Plage, Ronald Simon, et al.
European Urology Open Science|April 13, 2026
Role of Local Treatment to the Prostate in Patients With de Novo Low-volume Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Receptor Pathway InhibitorsPhilipp Mandel, Mike Wenzel, Felix Chun, et al.
European Urology|January 25, 2017
Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy SpecimensGuido Sauter, Till Clauditz, Stefan Steurer, et al.
European Urology|June 18, 2018
Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate CancerWaldemar Wilczak, Corinna Wittmer, Till Clauditz, et al.
BJU International|November 13, 2020
Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statementZafer Tandogdu, Justin Collins, Greg Shaw, et al.
Cancer Cell|February 16, 2013
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancerJoachim Weischenfeldt, Ronald Simon, Lars Feuerbach, et al.
Cancer Cell|December 12, 2018
Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical TrajectoriesClarissa Gerhauser, Francesco Favero, Thomas Risch, et al.
Nature Reviews. Urology|September 2, 2025
The current landscape of single-port robotic surgery in urologyArianna Biasatti, Nicolas A Soputro, Francesco Porpiglia, et al.
European Journal of Epidemiology|November 10, 2019
Rationale and Design of the Hamburg City Health StudyAnnika Jagodzinski, Christoffer Johansen, Uwe Koch-Gromus, et al.
Pageof 85

Showing results (841-850 of 850) with videos related to

Sort By:
Pageof 85
You have reached the last page of results.This site can display upto 850 results.
European Urology Oncology|June 28, 2021
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal TherapyCarlo A Bravi, Matteo Droghetti, Nicola Fossati, et al.
Prostate Cancer and Prostatic Diseases|November 4, 2025
High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancerNeele Heckmann, Henning Plage, Ronald Simon, et al.
European Urology Open Science|April 13, 2026
Role of Local Treatment to the Prostate in Patients With de Novo Low-volume Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Receptor Pathway InhibitorsPhilipp Mandel, Mike Wenzel, Felix Chun, et al.
European Urology|January 25, 2017
Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy SpecimensGuido Sauter, Till Clauditz, Stefan Steurer, et al.
European Urology|June 18, 2018
Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate CancerWaldemar Wilczak, Corinna Wittmer, Till Clauditz, et al.
BJU International|November 13, 2020
Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statementZafer Tandogdu, Justin Collins, Greg Shaw, et al.
Cancer Cell|February 16, 2013
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancerJoachim Weischenfeldt, Ronald Simon, Lars Feuerbach, et al.
Cancer Cell|December 12, 2018
Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical TrajectoriesClarissa Gerhauser, Francesco Favero, Thomas Risch, et al.
Nature Reviews. Urology|September 2, 2025
The current landscape of single-port robotic surgery in urologyArianna Biasatti, Nicolas A Soputro, Francesco Porpiglia, et al.
European Journal of Epidemiology|November 10, 2019
Rationale and Design of the Hamburg City Health StudyAnnika Jagodzinski, Christoffer Johansen, Uwe Koch-Gromus, et al.
Pageof 85